Literature DB >> 21834614

Use of Salvia divinorum in a nationally representative sample.

Brian E Perron1, Brian K Ahmedani, Michael G Vaughn, Joseph E Glass, Arnelyn Abdon, Li-Tzy Wu.   

Abstract

BACKGROUND: Salvia divinorum has known hallucinogenic effects and is legal in most parts of the United States. Given that this psychoactive substance has a potential of misuse and abuse, further data regarding the clinical and psychosocial factors associated with use are needed.
OBJECTIVES: To examine the clinical and psychosocial characteristics associated with use of salvia.
METHODS: The study uses data from the National Survey on Drug Use and Health, 2008 (N = 55,623).
RESULTS: The results of this study suggest that salvia use is most common among young adults aged 18-25 years as well as individuals who had engaged in risk-taking behaviors (selling illicit drugs, stealing) or illicit drug use (especially other hallucinogens/ecstasy). Self-reported depression and anxiety were also associated with salvia use. CONCLUSIONS/SCIENTIFIC SIGNIFICANCE: The results provide evidence that salvia use is part of a broader constellation of psychosocial and behavioral problems among youth and young adults. The accessibility, legal status, and psychoactive effects of salvia can be a potentially complicating health risk to young people, especially among those with existing substance use problems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21834614      PMCID: PMC3408869          DOI: 10.3109/00952990.2011.600397

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  14 in total

1.  Toward a psychology of positive youth development.

Authors:  R W Larson
Journal:  Am Psychol       Date:  2000-01

2.  Pattern of use and subjective effects of Salvia divinorum among recreational users.

Authors:  Débora González; Jordi Riba; José Carlos Bouso; Gregorio Gómez-Jarabo; Manel J Barbanoj
Journal:  Drug Alcohol Depend       Date:  2006-05-23       Impact factor: 4.492

Review 3.  Legally high? Legal considerations of Salvia divinorum.

Authors:  O Hayden Griffin; Bryan Lee Miller; David N Khey
Journal:  J Psychoactive Drugs       Date:  2008-06

4.  Salvia divinorum use and phenomenology: results from an online survey.

Authors:  H R Sumnall; F Measham; S D Brandt; J C Cole
Journal:  J Psychopharmacol       Date:  2010-10-11       Impact factor: 4.153

5.  Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).

Authors:  R Bücheler; C H Gleiter; P Schwoerer; I Gaertner
Journal:  Pharmacopsychiatry       Date:  2005-01       Impact factor: 5.788

6.  Adolescent salvia substance abuse.

Authors:  Sundeep Singh
Journal:  Addiction       Date:  2007-05       Impact factor: 6.526

7.  Internet access to Salvia divinorum: implications for policy, prevention, and treatment.

Authors:  Valerie Hoover; Douglas B Marlowe; Nicholas S Patapis; David S Festinger; Robert F Forman
Journal:  J Subst Abuse Treat       Date:  2007-10-10

Review 8.  Hallucinogens and dissociative agents naturally growing in the United States.

Authors:  John H Halpern
Journal:  Pharmacol Ther       Date:  2004-05       Impact factor: 12.310

9.  Salvia divinorum and salvinorin A: new pharmacologic findings.

Authors:  D J Siebert
Journal:  J Ethnopharmacol       Date:  1994-06       Impact factor: 4.360

10.  Salvia divinorum: effects and use among YouTube users.

Authors:  James E Lange; Jason Daniel; Kestrel Homer; Mark B Reed; John D Clapp
Journal:  Drug Alcohol Depend       Date:  2009-12-23       Impact factor: 4.492

View more
  8 in total

1.  Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.

Authors:  Mohini Ranganathan; Ashley Schnakenberg; Patrick D Skosnik; Bruce M Cohen; Brian Pittman; R Andrew Sewell; Deepak Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2012-07-18       Impact factor: 13.382

2.  Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.

Authors:  Ryan Vandrey; Matthew W Johnson; Patrick S Johnson; Miral A Khalil
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2013-04

Review 3.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

4.  Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.

Authors:  Matthew W Johnson; Katherine A MacLean; Michael J Caspers; Thomas E Prisinzano; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2016-02-15       Impact factor: 4.153

5.  Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence.

Authors:  Antoine Karam; Aida Said; Chafika Assaad; Souheil Hallit; Georges Haddad; Dory Hachem; Francois Kazour
Journal:  Community Ment Health J       Date:  2018-10-29

6.  Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.

Authors:  Katherine A MacLean; Matthew W Johnson; Chad J Reissig; Thomas E Prisinzano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2012-11-08       Impact factor: 4.530

Review 7.  Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects.

Authors:  Andreia Machado Brito-da-Costa; Diana Dias-da-Silva; Nelson G M Gomes; Ricardo Jorge Dinis-Oliveira; Áurea Madureira-Carvalho
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-03

Review 8.  Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders.

Authors:  Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Front Pharmacol       Date:  2015-09-08       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.